ClinicalTrials.Veeva

Menu

COVID-19 Glycemic Control Study

L

Leiden University Medical Center (LUMC)

Status

Completed

Conditions

Type 1 Diabetes
Type 2 Diabetes

Treatments

Other: No interventions, observational study

Study type

Observational

Funder types

Other

Identifiers

NCT05977205
NL73778.058.20

Details and patient eligibility

About

Diabetes mellitus is a chronic disease characterized by the inability of the body to maintain normoglycemia. Treatment of diabetes relies mostly on diabetes self-management, requiring a large investment of time and energy on a daily basis. Psychological wellbeing, behavioral patterns and social context play a major role in diabetes self-management and glycemic control. Social isolation behavior (self-quarantining) may impact glycemic control by influencing daily routines, therapy adherence, physical activity, and self-measurement and eating behaviors. Therefore, a period of nationwide self-quarantine, such as during the lockdown issued during the COVID-19 outbreak in the Netherlands, may have a large effect on glycemic control in patients with diabetes.

In this observational cross sectional study, we aim to assess the impact of long-term self-quarantine on glycemic control, diabetes self-management and distress in patients with type 1 and type 2 diabetes mellitus.

A specific subgroup of patients with T1D are those with complicated diabetes who have received a pancreas or islet transplantation and use immunosuppression, having multiple risk factors for severe COVID-19. The impact of lockdown strategies on mental and physical health is expectedly even greater in patients at even higher risk for severe COVID-19. We therefore additionally investigated differences in behavioral, mental and physical implications of a nationwide lockdown on patients with type 1 diabetes with and without islet or pancreas transplantation.

Measurements will be performed during the lockdown period. Patients will be asked to perform a fingerprick HbA1c measurement once, sent back to the LUMC by mail. Data from continuous or flash glucose monitoring devices will be collected according to standard clinical practice. Furthermore, patients will be asked to fill out an online questionnaire once on diabetes self-management behavior, well-being and distress, along with questions about health status, level of education, medication use, employment, social situation and the impact of self-quarantine on daily routines. In this questionnaire, we ask patients to compare certain aspects of their life (e.g. anxiety, stress, weight, physical activity, glycemic control) at the time of the lockdown to before the lockdown. Data on demographics, type of diabetes, weight, BMI and HbA1c prior to the COVID-19 outbreak will be derived from the patient's electronic health file.

Enrollment

492 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Diagnosed with type 1 or type 2 diabetes
  • Ability to perform fingerpricks
  • Sufficient comprehension of the Dutch language
  • Ability to fill out online questionnaires

Exclusion criteria

  • Pregnancy
  • Newly diagnosed malignancy, with the exclusion of non-melanoma skin cancer, in the previous 6 months
  • Chemotherapy or immunotherapy for malignancy
  • Admission to hospital or rehabilitation center

Trial design

492 participants in 3 patient groups

Type 1 Diabetes
Description:
280 patients with type 1 diabetes
Treatment:
Other: No interventions, observational study
Type 2 Diabetes
Description:
155 patients with type 2 diabetes
Treatment:
Other: No interventions, observational study
Type 1 Diabetes with Islet or Pancreas Transplantation
Description:
23 patients with islet transplantation, 7 with pancreas transplantation, 27 with simultaneous pancreas-kidney transplantation
Treatment:
Other: No interventions, observational study

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems